India Veterinary Reference Laboratory Market Overview, 2031

Key Insights

• India's veterinary reference laboratory market is positioned within one of the world's largest and most diverse animal populations, creating unique dynamics for veterinary diagnostic demand. According to the 20th Livestock Census (2019), India has 535.78 million livestock animals, including 192.49 million cattle, 148.88 million goats, 109.85 million buffaloes, 74.26 million sheep, and 9.06 million pigs. The companion animal population is estimated at 35 million pets, with the total population of dogs and cats including strays reaching approximately 100 million.
• The Indian veterinary reference laboratory market is characterized by a dual public-private infrastructure network. The Department of Animal Husbandry and Dairying (DAHD) maintains a network of diagnostic laboratories that includes one Central Disease Diagnostic Laboratory (CDDL) at the Indian Veterinary Research Institute (IVRI), Bareilly, and five Regional Disease Diagnostic Laboratories (RDDLs) located at Bengaluru, Pune, Jalandhar, Kolkata, and Guwahati. These facilities support disease surveillance, early detection, and swift response to disease threats. As of 2025, nine State-level laboratories have achieved National Accreditation Board for Testing and Calibration Laboratories (NABL) accreditation, with Andhra Pradesh (2), Kerala (4), Uttarakhand (2), and Karnataka (1) leading the states. The Indian Council of Agricultural Research (ICAR)-National Institute on Veterinary Epidemiology and Disease Informatics (NIVEDI), Bengaluru, provides disease risk forewarnings using Artificial Intelligence and machine learning models for 15 economically important diseases through the NADRES V2 portal.
• Regulatory oversight for veterinary diagnostics in India operates under a framework administered by DAHD, with the Ministry of Fisheries, Animal Husbandry and Dairying providing policy direction. The Livestock Health and Disease Control Programme (LHDCP) provides 100% central assistance to States/UTs for vaccination against Foot and Mouth Disease (FMD), Brucellosis, Peste des Petits Ruminants (PPR), Classical Swine Fever (CSF), Lumpy Skin Disease (LSD), and other diseases, including disease surveillance and capacity building.
• The Indian veterinary reference laboratory market is seeing increasing participation from both domestic and multinational diagnostic manufacturers. The competitive landscape is characterized by strategic partnerships and public-private collaborations. The Department of Animal Husbandry and Dairying, in collaboration with the World Organisation for Animal Health (WOAH), organized the WOAH PVS-PPP Targeted Support Workshop in February 2025, establishing a roadmap for Public-Private Partnerships in veterinary services.

Market Outlook
• According to the research report, "India Veterinary Reference Laboratory Market Overview, 2031 Overview, 2031," published by Bonafide Research, the India Veterinary Reference Laboratory market is anticipated to grow at more than 11.75% CAGR from 2026 to 2031.
• A defining characteristic of the Indian veterinary reference laboratory market is the rapid modernization of diagnostic services driven by the dual imperatives of managing a vast livestock population and meeting the growing healthcare expectations of an expanding urban pet-owning class. The adoption of molecular diagnostics, including PCR and next-generation sequencing, has accelerated significantly, driven by large-scale disease outbreaks. The Lumpy Skin Disease (LSD) outbreak that began in 2022 demonstrated the critical importance of advanced diagnostics, with molecular screening using PCR revealing that nasal swabs exhibited the highest detection rate (95%), followed by tissue biopsies (82%), whereas blood samples showed lower detection efficiency (55%). Multiplex PCR panels capable of detecting multiple pathogens and antimicrobial resistance (AMR) genes simultaneously are being increasingly adopted, offering comprehensive screening capabilities. The Department of Animal Husbandry and Dairying has strengthened AMR surveillance through the All India Network Programme on AMR (AINP-AMR), involving 31 centres across different states, and the Indian Network for Fishery and Animal Antimicrobial Resistance (INFAAR), conducting AMR surveillance in food animals and aquaculture.
• India's national veterinary reference laboratory network, comprising the CDDL at IVRI, five RDDLs, and state-level laboratories, provides the backbone of the country's veterinary diagnostic infrastructure. The network supports active disease surveillance for Avian influenza, Peste des Petits Ruminants (PPR), Classical Swine Fever (CSF), and Foot and Mouth Disease (FMD), with ICAR-NIVEDI providing AI-based disease risk forewarnings. The government has formulated the National Action Plan on Antimicrobial Resistance (AMR) in consultation with the Ministry of Health and Family Welfare, emphasizing One Health principles. Technological advancements, including digital platforms and AI-based tools for data handling, are reshaping the diagnostic landscape, with cloud-based platforms and AI assisting in aggregating and analyzing AST data to enhance resistance pattern prediction.
• The market also reflects India's strategic emphasis on animal health security and the government's comprehensive approach to modernizing veterinary infrastructure. In January 2026, the DAHD introduced comprehensive national guidelines for veterinary clinics and hospitals, establishing minimum infrastructure and staffing norms for the first time in India's history. The guidelines introduce a structured four-tier institutional system: Primary Veterinary Care Centres (PVCCs) serving clusters of gram panchayats, Block Veterinary Hospitals at the tehsil level, District Veterinary Hospitals as regional hubs for emergency care and advanced diagnostics, and State Veterinary Polyclinics and Super Speciality Hospitals at the apex level offering specialized services including virology, digital imaging, and dental care. The veterinary clinics and hospitals market is valued at $2.1 billion, with approximately 30,184 government-run veterinary dispensaries, 24,532 aid centres, 13,173 hospitals, and about 10,000 private veterinary clinics serving the country's animal population.



Market Dynamics

Driver: Vast livestock population and growing pet ownership driving demand for veterinary diagnostics.
The Indian veterinary reference laboratory market is primarily driven by the country's massive livestock population and expanding companion animal ownership. With 535.78 million livestock animals, India possesses one of the world's largest livestock populations, creating substantial demand for herd health management, disease surveillance, and diagnostic testing. The dairy sector alone produced 230.58 million tons of milk in 2022-23, with per capita availability of 459 grams per day, reflecting the scale of livestock operations requiring veterinary oversight. The pet population, estimated at 35 million and growing at 6.5% annually, represents an expanding addressable market for reference laboratory services, with pet owners increasingly seeking advanced diagnostic options.

Challenge: Uneven distribution of diagnostic infrastructure and workforce shortages
A principal challenge facing the Indian veterinary reference laboratory market is the uneven distribution of diagnostic infrastructure and the persistent shortage of specialized veterinary professionals. While the national reference laboratory network includes the CDDL and five RDDLs, as of 2025 only nine State laboratories have achieved NABL accreditation, indicating significant gaps in laboratory quality standards across the country. The Department has issued advisories to all States/UTs for NABL accreditation, but progress remains uneven. Geographic disparities persist, with diagnostic infrastructure concentrated in major urban and industrial areas, while many rural regions lack access to advanced reference laboratory services.



Trend: Expansion of molecular diagnostics and integrated One Health surveillance
The Indian veterinary reference laboratory market is experiencing a significant shift toward molecular diagnostics and integrated One Health surveillance systems. The Lumpy Skin Disease outbreak that began in 2022 and continued through 2025 transformed the veterinary diagnostics landscape, dramatically accelerating adoption of PCR testing across both government and commercial laboratories. Molecular screening during the 2025 LSD outbreaks revealed distinct diagnostic patterns, with nasal swabs showing the highest PCR detection rate (95%) compared to tissue biopsies (82%) and blood samples (55%), informing best practices for field diagnostics. Multiplex PCR panels capable of detecting multiple pathogens and AMR genes simultaneously are being rapidly adopted, offering comprehensive screening capabilities and improved laboratory efficiency.

Policies

• Livestock Health and Disease Control Programme (LHDCP): The government's flagship program providing 100% central assistance to States/UTs for vaccination against Foot and Mouth Disease (FMD), Brucellosis, Peste des Petits Ruminants (PPR), Classical Swine Fever (CSF), Lumpy Skin Disease, and other diseases, including disease surveillance, monitoring, and capacity building.
• National Action Plan on Antimicrobial Resistance (AMR): Formulated by the Department of Animal Husbandry and Dairying in consultation with the Ministry of Health and Family Welfare, the plan emphasizes judicious use, surveillance, and monitoring of antibiotics in the animal health sector. The All India Network Programme on AMR (AINP-AMR) involves 31 centres across different states, and the Indian Network for Fishery and Animal Antimicrobial Resistance (INFAAR) conducts AMR surveillance in food animals and aquaculture.
• NABL Accreditation Policy: The Department of Animal Husbandry and Dairying has issued advisories to all States/UTs for NABL accreditation of veterinary laboratories for disease surveillance and control. As of 2025, nine State laboratories across Andhra Pradesh (2), Kerala (4), Uttarakhand (2), and Karnataka (1) have achieved accreditation.
• National Veterinary Laboratory Network: The DAHD maintains a network including one Central Disease Diagnostic Laboratory (CDDL) at the Indian Veterinary Research Institute (IVRI), Bareilly, and five Regional Disease Diagnostic Laboratories (RDDLs) at Bengaluru, Pune, Jalandhar, Kolkata, and Guwahati for disease surveillance and early detection. The government supports laboratory strengthening under the LHDCP and the Pandemic Fund Project on Animal Health Security Strengthening in India for Pandemic Preparedness and Response.
• National Guidelines for Veterinary Clinics and Hospitals (2026): Introduced in January 2026, these comprehensive national guidelines establish minimum infrastructure and staffing norms for the first time in India's history. The framework introduces a four-tier institutional system: Primary Veterinary Care Centres, Block Veterinary Hospitals, District Veterinary Hospitals, and State Veterinary Polyclinics and Super Speciality Hospitals.
• WOAH PVS-PPP Roadmap:The Department of Animal Husbandry and Dairying, in collaboration with the World Organisation for Animal Health (WOAH), established a Public-Private Partnership roadmap for veterinary services in February 2025, emphasizing establishment of NABL-accredited district-level laboratories, FMD-Free Zone development, and private sector participation.

Market Overview, 2031 Segment Analysis

India Veterinary Reference Laboratory Market Overview, 2031 By Service Type
• Clinical Chemistry represents the largest revenue-generating service category in the Indian veterinary reference laboratory market, driven by the high volume of routine blood chemistry panels and metabolic profiling tests performed across companion animal and livestock healthcare settings. Clinical chemistry services are utilized for routine wellness testing, disease diagnosis, treatment monitoring, and pre-surgical assessment, with adoption concentrated within veterinary hospitals, specialty referral centers, and reference laboratories. The growing emphasis on preventive care and early disease detection, coupled with the government's focus on livestock productivity, continues to drive demand for comprehensive chemistry panels.
• Immunodiagnostics represents a significant and rapidly growing service category in India, enabling rapid and accurate detection of infectious and chronic diseases in companion and livestock animals. Immunodiagnostic services include ELISA-based testing, serological assays, rapid test kits, and immunofluorescence, supporting infectious disease screening, vaccine titer monitoring, and endocrine disorder diagnosis. The national surveillance programs for FMD, Brucellosis, PPR, and CSF utilize immunodiagnostic assays for screening and confirmation. Rapid test kits have gained popularity in veterinary clinics, providing point-of-care diagnostic options, while reference laboratory-based immunoassays remain essential for comprehensive testing and confirmation. The diagnostic capacity for zoonotic diseases was strengthened with the dedication of a new leptospirosis reference laboratory at ICAR-NIVEDI in Bengaluru in January 2025.
• Molecular Diagnostics represents the fastest-growing service category in the Indian market and is projected to grow at the highest CAGR through 2033. The Lumpy Skin Disease outbreak that began in 2022 served as a transformative event, establishing PCR testing as a critical diagnostic modality and accelerating adoption across the veterinary sector. Molecular tools like PCR and sequencing are increasingly used for precise identification of resistance genes, offering rapid results that help veterinarians select targeted therapies, reducing unnecessary antibiotic use, and limiting AMR spread. The All India Network Programme on AMR, involving 31 centres across different states, utilizes molecular diagnostics for surveillance. During the 2025 LSD outbreaks, molecular screening of clinical samples demonstrated PCR positivity variation among sample types, with nasal swabs exhibiting the highest detection rate (95%, 19/20), followed by tissue biopsies (82%, 9/11), whereas blood samples showed lower detection efficiency (55%, 5/9). Beyond infectious disease testing, molecular diagnostics are increasingly utilized for genetic screening and research applications, with ICAR-NIVEDI providing AI-based disease risk forewarnings using machine learning models.
• Others encompasses microbiology, parasitology, toxicology, and anatomic pathology services. These specialized services are critical for comprehensive diagnostic workups and are typically outsourced to reference laboratories due to the specialized equipment and expertise required. Parasitology testing remains essential for routine wellness screening, particularly in livestock production. Anatomic pathology supports cancer diagnosis and surgical planning, with growing demand driven by increased cancer incidence in aging pets. Toxicology testing is increasingly important for food safety and export compliance in India's livestock production sector, which exported products valued at ₹66,249 crore in FY25.

India Veterinary Reference Laboratory Market Overview, 2031 By Animal Type
• Companion Animals represent the largest revenue-generating animal type segment in the Indian veterinary reference laboratory market, driven by the expanding pet population and increasing pet healthcare expenditure. With an estimated pet population of 35 million, growing at 6.5% annually, and a broader population of dogs and cats exceeding 100 million including strays, the companion animal segment accounts for the largest revenue share. The growing prevalence of chronic conditions in aging pets drives demand for routine and specialized diagnostic testing. Urban pet ownership has intensified demand for advanced diagnostics, with pet owners increasingly willing to invest in comprehensive veterinary care.
• Production Animals represent a substantial segment of the Indian market and are forecast to experience the fastest growth rate through 2033. India's livestock population of 535.78 million, including 192.49 million cattle, 148.88 million goats, 109.85 million buffaloes, 74.26 million sheep, and 9.06 million pigs, drives substantial demand for herd health management, food safety testing, reproductive testing, and disease surveillance. The national animal disease surveillance system, coordinated by DAHD through the CDDL, RDDLs, and state laboratories, conducts surveillance programs for FMD, Brucellosis, PPR, CSF, Avian influenza, and LSD.

India Veterinary Reference Laboratory Market Overview, 2031 By End User
• Veterinary Hospitals and Clinics represent the largest end-user segment in the Indian veterinary reference laboratory market. With approximately 30,184 government-run veterinary dispensaries, 24,532 aid centres, 13,173 hospitals, and about 10,000 private veterinary clinics, general practices increasingly outsource complex tests to reference laboratories. The DAHD introduced comprehensive national guidelines for veterinary clinics and hospitals in January 2026, establishing minimum infrastructure and staffing norms that will drive demand for reference laboratory services as facilities upgrade their diagnostic capabilities. The guidelines mandate higher-tier facilities to have dedicated operation theatres, biochemical labs, biosafety level labs, and post-mortem facilities, creating opportunities for reference laboratories to partner with government veterinary facilities. Corporate veterinary hospital chains, including Max Vets, Cessna Lifeline, Crown Veterinary Services, Dr. Paws, and Urban Vet, have consolidated reference laboratory purchasing decisions and are driving demand for standardized diagnostic services.
• Research Institutes represent a significant end-user segment in India. Academic veterinary institutions, pharmaceutical research organizations, and animal-health research institutions rely on reference laboratories for advanced molecular testing, genetic analysis, and disease surveillance studies. Leading research institutions including the Indian Veterinary Research Institute (IVRI), ICAR-NIVEDI Bengaluru, the National Institute of Animal Health, and various state agricultural universities conduct research programs that rquire high-complexity reference laboratory testing. The dedication of a new leptospirosis reference laboratory at ICAR-NIVEDI in Bengaluru in January 2025 enhanced research and surveillance capabilities for zoonotic diseases. In October 2024, Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana, received INR 29 lakhs from India's Department of Biotechnology to create a sophisticated diagnostic device for pig disease detection using Tetra ARMS PCR and computational tools. Research institutes demand research-grade analytics and specialized testing services, driving demand for high-complexity reference laboratory testing, particularly in the fields of AMR research and molecular epidemiology.

India Veterinary Reference Laboratory Procedure Economics
• Veterinary reference laboratory testing in India represents a critical component of comprehensive veterinary care, requiring specialized equipment, trained personnel, quality control, and timely reporting. The market is characterized by a mix of government-funded and private laboratory services, with price sensitivity being a significant factor in consumer decisions.
• The competitive landscape includes both domestic and multinational diagnostic manufacturers. Global leaders including IDEXX Laboratories and Zoetis Inc. maintain presence in India, while domestic manufacturers such as Hester Biosciences, Biovet, and Virbac India have expanded their veterinary diagnostic portfolios. The Indian Federation of Animal Health Companies (INFAH) represents industry stakeholders. In October 2024, Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana, received INR 29 lakhs from India's Department of Biotechnology to create a sophisticated diagnostic device for pig disease detection, demonstrating ongoing innovation in veterinary diagnostics.
• In veterinary hospitals and clinics, the cost of a comprehensive diagnostic workup including clinical chemistry, hematology, and immunodiagnostics ranges from approximately INR 1,500 to INR 5,000 depending on the complexity of the test panel, geographic location, and laboratory pricing.
• In research institutes, the cost of advanced molecular testing and genetic analysis varies widely depending on the complexity of the assay, sample volume, and research protocols. Academic institutions often negotiate volume discounts and research pricing with reference laboratories. The national surveillance program receives government funding to support diagnostic testing for notifiable diseases, reducing costs for participating laboratories and ensuring surveillance coverage.

Market Overview, 2031 Outlook by Healthcare Spending and Infrastructure
• Indian veterinary reference laboratory market growth is strongly linked to livestock sector development, pet healthcare expenditure, and veterinary infrastructure modernization. With India's livestock population of 535.78 million and a companion animal population of 35 million, the addressable market continues to expand. The livestock sector contributed 5.49% (₹8.86 trillion) to India's total GVA at current prices in FY24, with exported products reaching ₹66,249 crore in FY25. Pet ownership is growing at 6.5% annually, driving increased expenditure on veterinary care. The veterinary clinics and hospitals market is valued at $2.1 billion, reflecting significant healthcare spending on animals.
• Veterinary healthcare infrastructure continues to expand and modernize across India. The DAHD maintains a network including the CDDL at IVRI Bareilly, five RDDLs, and numerous State laboratories. Government investment under the LHDCP and the Pandemic Fund Project on "Animal Health Security Strengthening in India for Pandemic Preparedness and Response" has supported laboratory strengthening, capacity building, and infrastructure enhancement. The introduction of comprehensive national guidelines for veterinary clinics and hospitals in January 2026 establishes a four-tier institutional system and mandates specific physical requirements, including animal examination areas, minor surgery units, medicine-dispensing rooms, and specialized diagnostic facilities at higher tiers.
• Private healthcare expenditure plays an increasingly important role, especially for advanced diagnostic testing and specialty veterinary care. Private veterinary hospitals and specialty referral centers in metropolitan regions are expanding diagnostic capabilities to capture demand for comprehensive testing services. Corporate veterinary hospital chains, including Max Vets, Cessna Lifeline, Crown Veterinary Services, Dr. Paws, and Urban Vet, have consolidated reference laboratory purchasing decisions and are driving demand for standardized diagnostic services. The WOAH PVS-PPP roadmap established in February 2025 aims to structure private sector participation in veterinary services, including the establishment of NABL-accredited district-level laboratories and FMD-Free Zones. The absence of a formal PPP policy for veterinary disease surveillance, however, limits expansion of commercial reference laboratory services.
• Public healthcare investment remains foundational to the market's growth. The Department provides financial support to all States and Union Territories including RDDLs and ICAR laboratories for strengthening disease diagnostic infrastructure under the LHDCP and Pandemic Fund Project. The government's National Action Plan on AMR and the All India Network Programme on AMR, involving 31 centres across different states, support diagnostic capacity building for antimicrobial resistance surveillance. The expansion of the Central Drug Laboratory functions at CCS-NIAH, Baghpat, for veterinary vaccine testing from 2 to 42 types reflects ongoing investment in veterinary diagnostic infrastructure.
• The future growth opportunity for veterinary reference laboratories in India depends on improving access to specialized diagnostic services, expanding the network of NABL-accredited laboratories, increasing adoption of molecular diagnostics and antimicrobial susceptibility testing, strengthening One Health surveillance systems, and continuing to advance diagnostic technologies. The government's focus on the livestock sector as a contributor to agricultural GVA, combined with the growing humanization of pets in urban areas, provides a favorable policy environment for continued market growth. The Department of Animal Husbandry and Dairying, ICAR, and the network of veterinary research institutions remain critical to protecting Indian animal health, public health, and the security of the food supply. 


Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031

Aspects covered in this report
• Veterinary Reference Laboratory Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Service Type
• Clinical Chemistry
• Hematology
• Immunodiagnostics
• Molecular Diagnostics
• Others

By Animal Type
• Companion Animals
• Livestock Animals

By End User
• Veterinary Hospitals and Clinics
• Research Institutes
• In-House Laboratories